Building the case for vaccine manufacturing in Africa
June 15, 2021
Africa remains inherently dependent on foreign suppliers for its vaccination requirements. As the COVID-19 pandemic has shown, as well as other epidemic outbreaks in the recent past, vaccines are a necessary requirement to bounce back from such negative shocks.
This dependency, highlighted by the fact that Africa imports 99% of its vaccination needs, is a serious challenge for Africa’s health resilience.
We believe that vaccine manufacturing is not just a case of opening a stand-alone factory in several countries across the continent. On the other hand, it needs to be seen as a broader ecosystem which has the power to develop into an economic sector providing quality employment, career opportunities, economic value-add and societal benefits. This report is our contribution to the debate.
The global COVID-19 pandemic presents a unique moment for leaders across the public, private, and social sectors to align on the importance and potential for developing this sector. The case for homegrown vaccine manufacturing is by no means obvious, but with the right level of commitment and support it is not out of reach for some countries.